Nitrofurantoin
Composition
The formulation Contains nitrofurantoin as the active ingredient.
Indications
Bacterial infections
Side effects
Urinary tract infections
Precautions
Nausea, headache, dizziness and allergic reaction
Contraindications
Contraindicated in patients with a history of hypersensitivity to nitrofurantoin or any component of the formulation, as well as renal impairment with a creatinine clearance below 60 mL/min
Dosage and administration
100 mg twice daily for 7 days
Countries
USA, UK, Canada
Available Forms
Sustained-release tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai